Description
Due to the current situation with COVID-19 we have decided that the event will be held online.
Please, find out the latest information about this online course on www.e-ESO.net.
Chairs: J.Y. Blay, FR - P.G. Casali, IT - R.A. Stahel, CH
The “ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers” is an educational effort held on an annual basis and conceived to strengthen the education of medical professionals willing to devote their career to rare cancers.
Despite being rare as single entities, rare adult solid cancers account for as many as 15% of all new cancer cases, thus being the main group within rare cancers in general. The definition of rare cancers by the RARECARE project and the list of the 10 “families” of rare adult solid cancers gave rise to shape the sessions of this course:
• Head & neck cancers
• Sarcomas
• Rare thoracic tumors
• Neuroendocrine tumors
• Central nervous system neoplasms
• Rare female genital cancers
• Endocrine gland tumors
• Digestive rare cancers
• Rare urological and male genital tumors
• Rare skin cancers & non-cutaneous melanoma
Since ‘networking’ and ‘multidisciplinarity’ are the two main keywords to improve the quality of care of rare cancers, ESO has decided to develop the programme of this course in collaboration with other the European initiatives in this field and to give its contribution to tackle the rare cancer issue. The 5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers is conceived in the context of, and supported by, EURACAN, the European Reference Network on rare adult solid cancers. The Faculty has been largely selected from EURACAN, also with the aim of letting this educational effort closely interact with its networking activities.
Optimal management of rare adult solid cancers poses specific diagnostic and therapeutic challenges. The sessions of the course have been designed to address the needs of clinical oncologists wanting an update on recent advancements on these tumours.
The global health crisis caused by the Covid-19 pandemic has forced us to turn the in-person course into a virtual event. It will be a good opportunity to receive updates on the available evidence in this field and promote future networking and collaborations.
We have done our best to design an online course enabling participants to attend according to their own schedule. There will be a mixture of pre-recorded sessions and live sessions for Q & A and clinical case discussions with faculty members and moderators.
Paolo Casali
On behalf of the co-Chairs
LEARNING OBJECTIVES
Provide an update on the latest developments in the area of rare adult solid rare cancers, with a background perspective on state-of-the-art and evidence based practice.
INFORMATION
The course will be carried out in two different steps:
Step 1
Pre-recorded sessions will be made available from 1st December 2020 and will remain on the e-eso website. You will be able to see all the sessions in your own time, and send questions that will be selected for discussion during Step 2 of the course;
Step 2
Live sessions with an introductory round table on rare cancers in general, clinical case presentations and Q&A discussions with moderators and speakers will be held on 16 and 17 January 2021.
During the Q&A sessions, speakers will answer and discuss a number of selected questions received in advance via email (see below for instructions) and/or during the live streaming via chat.
Q&A SESSIONS
Participants are encouraged to send questions in advance, as long as they listen to the recorded sessions. The moderators will select questions to be answered during the live streaming. Questions should be sent to raretumours@eso.net, no later than 4 January 2021. Please indicate the session title and speaker your question refers to.
All the contents will be recorded and accessible via the e-ESO website after the event (registration to access the contents will remain open).
The course is an ESO-ESMO-RCE joint event | |||||
Held in collaboration with | |||||
In partnership with |
|||||
Faculty
INVITED FACULTY
Tit Albreht, National Institute of Public Health, ., Ljubljana, SI
Martina Angi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Giulia Arrivi, Azienda Ospedaliero Universitaria Sant'Andrea, La Sapienza, Unità di Oncologia, Roma, IT
Stefanie Aust, Medical University of Vienna, AT
Judith Balmana, Vall d'Hebron Institute of Oncology, Medical Oncology Dept., Barcelona, ES
Eric Baudin, Institut Gustave-Roussy, Dept. of Nuclear Medicine and Endocrine Tumors, Villejuif, FR
Alfredo Berruti, ASST Spedali Civili, Brescia, IT
Jean-Yves Blay, Centre Léon Bérard, Lyon, FR
Jaume Capdevila, Vall d'Hebron University Hospital, Barcelona, ES
Martyn Caplin, Royal Free Hospital, London, UK
Paolo Giovanni Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Stefano Cavalieri, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Elena Colombo, IRCCS Istituto Nazionale Dei Tumori, Oncologia Medica 3, Milan, IT
Filippo De Braud, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Loris De Cecco, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Christelle de la Fouchardiere, Centre Léon Bérard, Lyon, FR
Francesco De Lorenzo, ECPC, European Cancer Patient Coalition, Brussels, BE
Marcello Deraco, Fondazione IRCCS Istituto NazionaleTumori, Milan, IT
Alexandru Eniu, Riviera-Chablais Vaud-Valais, Interdisciplinary Oncology Service (SIC), Rennaz, CH
Nicola Fazio, European Institute of Oncology, Milan, IT
Silvia Franceschi, Centro Riferimento Oncologico, Struttura Complessa Epidemiologia Oncologica, Aviano, IT
Anna Maria Frezza, Fondazione IRCCS Istituto NazionaleTumori, Milan, IT
Giulia Galli, Fondazione IRCCS Istituto Nazionale dei Tumori, Medical Oncology Dpt., Milano, IT
Marina Garassino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Jourik A. Gietema, University Medical Center, Groningen, NL
Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, London, UK
Vincent Gregoire, Centre Léon Bérard, Lyon, FR
Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Ellen Kapiteijn, University Medical Center, Leiden, NL
Heinz-Josef Klumpen, University of Amsterdam UMC, ., Amsterdam, NL
Ruth Ladenstein, St.Anna-Kinderspital, Children’s Cancer Research Institute, Vienna, AT
Celeste Lebbé, Saint Louis Hospital, Paris, FR
Lisa Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Laura Deborah Locati, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Domenica Lorusso, Policlinico Universitario Gemelli, Unità di Oncologia Ginecologica, Roma, IT
Andrea Necchi, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milan, IT
Monica Niger, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Kathy Oliver, International Brain Tumour Alliance, Tadworth, UK
Fedro Alessandro Peccatori, European Institute of Oncology, Milan, IT
Alessia Pellerino, City of Health and Science University Hospital, Dept. of Neuro-Oncology, Turin, IT
Cesare Piazza, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Sophie Piperno-Neumann, Curie Institute, Paris, FR
Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, FR
Carlo Resteghini, Fondazione IRCCS Istituto Nazionali Tumori, Milan, IT
Michael Seckl, Imperial College Hammersmith Campus, London, UK
Christian Simon, Centre Hospitalier Universitaire Vaudois, Lausanne, CH
Riccardo Soffietti, City of Health and Science University Hospital, Torino, IT
Silvia Stacchiotti, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Rolf A. Stahel, Comprehensive Cancer Center University Hospital, Zurich, CH
Sandra Strauss, UCL Cancer Institute, Medical Oncology Dept., London, GB
Thais Tong, Leiden University Medical Center, Medical Oncology Dept., Leiden, NL
Annalisa Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Martin J. Van den Bent, Erasmus M.C. Cancer Center, Rotterdam, NL
Lucjan Wyrwicz, Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, PL
General information
ORGANISING SECRETARIAT
European School of Oncology
Via Turati, 29
20121 Milan, Italy
Marina Fregonese - Event Organiser - mfregonese@eso.net
Dolores Knupfer - Event Organiser - dknupfer@eso.net
Mariachiara Deleo - e-ESO Assistant - mdeleo@eso.net
Francesca Marangoni - e-ESO Executive Manager - fmarangoni@eso.net
OFFICIAL LANGUAGE
The official language is English. Translation will not be provided.
CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email.
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 24 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
ESCO CREDITS
The Course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Course earns participants 22 ESCO credits.
Visit www.esco.org for information on how to join ESCO.
Registration
IDEAL PARTICIPANT’S PROFILE
• Medical degree
• Specialization/residency in medical oncology, radiation oncology, surgical oncology or equivalent
REGISTRATION
Registration for the event is free but mandatory.
REGISTER ONLINE HERE
CONFIRMATION OF REGISTRATION
Registration will be confirmed by e-mail.
All the contents will be recorded and accessible via the e-ESO website during and after the event
(registration to access the contents will remain open after the event).
Programme
1 December | ||
THE JOINT ACTION ON RARE CANCERS: WHAT NEXT? Pre-recorded sessions available from 1 December 2020 Jean-Yves Blay, FR - Fedro Alessandro Peccatori, IT | ||
The rare cancer agenda 2030 Paolo Giovanni Casali, IT | ||
The epidemiology of rare adult solid cancers Annalisa Trama, IT | ||
EURACAN: where we are? Jean-Yves Blay, FR | ||
An educational pathway on rare adult solid cancers Anna Maria Frezza, IT | ||
UPDATE ON RARE THORACIC CANCERS Pre-recorded sessions available from 1 December 2020 Marina Garassino, IT - Rolf A. Stahel, CH | ||
Mesothelioma Rolf A. Stahel, CH | ||
Thymic tumors Marina Garassino, IT | ||
UPDATE ON SARCOMAS Pre-recorded sessions available from 1 December 2020 Jean-Yves Blay, FR - Paolo Giovanni Casali, IT | ||
Adult soft tissue sarcomas Paolo Giovanni Casali, IT | ||
GIST Jean-Yves Blay, FR | ||
Ewing sarcoma and osteosarcoma Sandra Strauss, UK | ||
Rare bone and soft tissue sarcomas Silvia Stacchiotti, IT | ||
Improving the surgical margin in sarcomas Alessandro Gronchi, IT | ||
UPDATE ON HEAD AND NECK CANCERS Pre-recorded sessions available from 1 December 2020 Vincent Gregoire, FR - Lisa Licitra, IT | ||
Laryngeal & hypopharyngeal carcinoma Cesare Piazza, IT | ||
Oropharyngeal carcinoma Vincent Gregoire, FR | ||
Nasopharyngeal carcinoma & sinonasal cancers Lisa Licitra, IT | ||
Salivary gland tumors Laura Deborah Locati, IT | ||
Oral cavity tumors Christian Simon, CH | ||
Advances in molecular biology Loris De Cecco, IT | ||
UPDATE ON NEUROENDOCRINE TUMORS Pre-recorded sessions available from 1 December 2020 Martyn Caplin, UK - Filippo De Braud, IT | ||
Thoracic NETs Martyn Caplin, UK | ||
Gastroenteropancreatic NETs Nicola Fazio, IT | ||
UPDATE ON CNS TUMORS Pre-recorded sessions available from 1 December 2020 Riccardo Soffietti, IT - Martin J. Van den Bent, NL | ||
Gliomas Riccardo Soffietti, IT | ||
Rare CNS tumors Martin J. Van den Bent, NL | ||
Hereditary cancer risk syndromes Judith Balmana, ES | ||
UPDATE ON ENDOCRINE GLAND TUMORS Pre-recorded sessions available from 1 December 2020 Christelle de la Fouchardiere, FR - Lisa Licitra, IT | ||
Adrenal cancer Alfredo Berruti, IT | ||
Thyroid cancer Jaume Capdevila, ES | ||
The epidemiological evidence of sovradiagnosis Silvia Franceschi, IT | ||
UPDATE ON DIGESTIVE RARE CANCERS Pre-recorded sessions available from 1 December 2020 Filippo De Braud, IT - Lucjan Wyrwicz, PL | ||
Biliary tumors Heinz-Josef Klumpen, NL | ||
Anal carcinoma Robert Glynne-Jones, UK | ||
Peritoneal mesothelioma & pseudomyxoma Marcello Deraco, IT | ||
UPDATE ON RARE UROGENITAL CANCERS Pre-recorded sessions available from 1 December 2020 Jourik A. Gietema, NL - Andrea Necchi, IT | ||
Testicular cancer Jourik A. Gietema, NL | ||
Penile cancer Andrea Necchi, IT | ||
Survivorship as a healthcare issue Tit Albreht, SI | ||
High level views on survivorship. The cancer mission perspective. The commons of paediatric and adult cancer Ruth Ladenstein, AT | ||
UPDATE ON RARE FEMALE GENITAL CANCERS Pre-recorded sessions available from 1 December 2020 Fedro Alessandro Peccatori, IT - Michael Seckl, UK | ||
Non-epithelial ovarian tumors Isabelle Ray-Coquard, FR | ||
Trophoblastic tumors Michael Seckl, UK | ||
Vulvar and vaginal cancers Domenica Lorusso, IT | ||
UPDATE ON RARE SKIN TUMORS AND UVEAL MELANOMA Pre-recorded sessions available from 1 December 2020 Ellen Kapiteijn, NL - Sophie Piperno-Neumann, FR | ||
Merkel cell carcinoma Celeste Lebbé, FR | ||
Cutaneous adnexal malignancies Stefano Cavalieri, IT | ||
Uveal melanoma Martina Angi, IT | ||
16 January | ||
11:30 | LIVE SESSION - THE JOINT ACTION ON RARE CANCER: WHAT NEXT? Fedro Alessandro Peccatori, IT - Rolf A. Stahel, CH | |
11:30 | Introduction Fedro Alessandro Peccatori, IT - Rolf A. Stahel, CH | |
11:40 | Round table: The Rare Cancer Agenda 2030 Jean-Yves Blay, FR - Paolo Giovanni Casali, IT - Francesco De Lorenzo, IT - Alexandru Eniu, CH - Kathy Oliver, UK - Annalisa Trama, IT | |
12:10 | Q&A and General discussion | |
12:40 | LIVE SESSION - UPDATE ON RARE THORACIC CANCERS Marina Garassino, IT - Rolf A. Stahel, CH | |
12:40 | Q&A Marina Garassino, IT - Rolf A. Stahel, CH | |
13:00 | Clinical case discussion Giulia Galli, IT | |
13:30 | LIVE SESSION - UPDATE ON SARCOMAS Jean-Yves Blay, FR - Paolo Giovanni Casali, IT | |
13:30 | Q&A Jean-Yves Blay, FR - Paolo Giovanni Casali, IT - Alessandro Gronchi, IT - Silvia Stacchiotti, IT - Sandra Strauss, UK | |
13:50 | Clinical case discussion Anna Maria Frezza, IT | |
14:15 | LIVE SESSION - UPDATE ON HEAD & NECK CANCERS Vincent Gregoire, FR - Lisa Licitra, IT | |
14:15 | Q&A Loris De Cecco, IT - Vincent Gregoire, FR - Lisa Licitra, IT - Laura Deborah Locati, IT - Cesare Piazza, IT - Christian Simon, CH | |
14:35 | Clinical case discussion Carlo Resteghini, IT | |
15:00 | LIVE SESSION - UPDATE ON NEUROENDOCRINE TUMORS Eric Baudin, FR - Filippo De Braud, IT | |
15:00 | Q&A Eric Baudin, FR - Filippo De Braud, IT - Nicola Fazio, IT | |
15:20 | Clinical case discussion Giulia Arrivi, IT | |
15:45 | LIVE SESSION - UPDATE ON CNS TUMORS Riccardo Soffietti, IT - Martin J. Van den Bent, NL | |
15:45 | Q&A Judith Balmana, ES - Riccardo Soffietti, IT - Martin J. Van den Bent, NL | |
16:05 | Clinical case discussion Alessia Pellerino, IT | |
17 January | ||
11:30 | LIVE SESSION - UPDATE ON ENDOCRINE GLAND TUMORS Christelle de la Fouchardiere, FR - Lisa Licitra, IT | |
11:30 | Q&A Alfredo Berruti, IT - Jaume Capdevila, ES - Christelle de la Fouchardiere, FR - Silvia Franceschi, IT - Lisa Licitra, IT | |
11:50 | Clinical case discussion Elena Colombo, IT | |
12:15 | LIVE SESSION - UPDATE ON DIGESTIVE RARE CANCERS Filippo De Braud, IT - Lucjan Wyrwicz, PL | |
12:15 | Q&A Filippo De Braud, IT - Marcello Deraco, IT - Robert Glynne-Jones, UK - Heinz-Josef Klumpen, NL - Lucjan Wyrwicz, PL | |
12:35 | Clinical case discussion Monica Niger, IT | |
13:00 | LIVE SESSION - UPDATE ON RARE UROGENITAL CANCERS Jourik A. Gietema, NL - Andrea Necchi, IT | |
13:00 | Q&A Tit Albreht, SI - Jourik A. Gietema, NL - Ruth Ladenstein, AT - Andrea Necchi, IT | |
13:20 | Clinical case discussion | |
13:45 | LIVE SESSION - UPDATE ON RARE FEMALE GENITAL CANCERS Fedro Alessandro Peccatori, IT - Michael Seckl, UK | |
13:45 | Q&A Domenica Lorusso, IT - Fedro Alessandro Peccatori, IT - Isabelle Ray-Coquard, FR - Michael Seckl, UK | |
14:05 | Clinical case discussion Stefanie Aust, AT | |
14:30 | LIVE SESSION - UPDATE ON RARE SKIN TUMORS & UVEAL MELANOMA Ellen Kapiteijn, NL - Sophie Piperno-Neumann, FR | |
14:30 | Q&A Martina Angi, IT - Stefano Cavalieri, IT - Ellen Kapiteijn, NL - Celeste Lebbé, FR - Sophie Piperno-Neumann, FR | |
14:50 | Clinical case discussion Thais Tong, NL | |
15:05 | Closing remarks Paolo Giovanni Casali, IT |